News for Healthier Living

New Ovarian Cancer Drug Can Affect the Eyes, Suggests First Real-World Study

The first real-world study on mirvetuximab ocular toxicity shows more than 55 percent of patients experienced decreased vision due to corneal damage.

October 17, 2024


October 31 2024

October 30 2024

October 29 2024

October 28 2024

October 27 2024

October 26 2024

October 25 2024

October 24 2024

October 23 2024

October 22 2024

October 21 2024

October 20 2024

October 19 2024

October 18 2024

October 17 2024